Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05191420 · ClinicalTrials.gov registry record
Conversations You Want About Corona Virus Disease (COVID-19)
A clinical trial of Covid19, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 23,000
- Enrollment target
- 1
- Study location
NCT05191420 is a study of Covid19 that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 23,000 participants, above the 2,458-participant average among 94 other Covid19 trials with a reported enrollment target (836% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05191420, a study of Covid19, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 23,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Web-enabled virtual topical guide: develop virtual conversations for each concern and intensity level
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,000 participants |
| Start Date | 2022-03-09 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05191420
The ClinicalTrials.gov registry entry for NCT05191420 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 23,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,458-participant average among 94 other Covid19 trials with a reported enrollment target (836% higher). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 0 interventions.
NCT05191420 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05191420 about?
NCT05191420 is a clinical study titled "Conversations You Want About Corona Virus Disease (COVID-19)". Web-enabled virtual topical guide: develop virtual conversations for each concern and intensity level
What is the current status of trial NCT05191420?
This trial is currently recruiting. The enrollment target is 23,000 participants. The study started on 2022-03-09. Estimated completion is 2027-06.
What conditions does trial NCT05191420 study?
This clinical trial studies the following conditions: Covid19.
Who is sponsoring clinical trial NCT05191420?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05191420 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Defibrotide for the Treatment of Severe COVID-19
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.